Wells Fargo & Company Geron Corp Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Geron Corp stock. As of the latest transaction made, Wells Fargo & Company holds 289,394 shares of GERN stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

289,394

Previous 209,373 38.22%

Holding current value

$1.19 Million

Previous $690,000 77.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.1 - $5.09 $248,065 - $407,306	80,021 Added 38.22%	289,394 $1.23 Million
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $51,740 - $101,707	29,566 Added 16.44%	209,373 $690,000
Q4 2023 Feb 09, 2024	SELL	$1.74 - $2.31 $525,928 - $698,215	-302,258 Reduced 62.7%	179,807 $379,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $45,379 - $70,542	21,507 Added 4.67%	482,065 $1.02 Million
Q2 2023 Aug 15, 2023	BUY	$1.97 - $3.69 $89,757 - $168,123	45,562 Added 10.98%	460,558 $1.48 Million
Q1 2023 May 12, 2023	BUY	$2.14 - $3.4 $837,426 - $1.33 Million	391,321 Added 1652.89%	414,996 $900,000
Q4 2022 Feb 13, 2023	BUY	$2.03 - $2.42 $20,708 - $24,686	10,201 Added 75.71%	23,675 $57,000
Q3 2022 Nov 14, 2022	SELL	$1.67 - $2.94 $15,011 - $26,427	-8,989 Reduced 40.02%	13,474 $32,000
Q2 2022 Aug 12, 2022	SELL	$1.19 - $1.65 $29,563 - $40,990	-24,843 Reduced 52.52%	22,463 $34,000
Q1 2022 May 16, 2022	SELL	$0.99 - $1.6 $103,908 - $167,932	-104,958 Reduced 68.93%	47,306 $64,000
Q4 2021 Feb 14, 2022	BUY	$1.22 - $1.72 $168,739 - $237,894	138,311 Added 991.26%	152,264 $185,000
Q3 2021 Nov 15, 2021	BUY	$1.2 - $1.5 $283 - $354	236 Added 1.72%	13,953 $19,000
Q2 2021 Aug 16, 2021	SELL	$1.25 - $1.83 $46,298 - $67,781	-37,039 Reduced 72.97%	13,717 $19,000
Q1 2021 May 13, 2021	SELL	$1.52 - $2.1 $800,024 - $1.11 Million	-526,332 Reduced 91.2%	50,756 $79,000
Q4 2020 Feb 09, 2021	BUY	$1.55 - $2.05 $689,030 - $911,298	444,536 Added 335.37%	577,088 $916,000
Q3 2020 Nov 05, 2020	SELL	$1.59 - $2.19 $22,647 - $31,194	-14,244 Reduced 9.7%	132,552 $232,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $10,491 - $21,782	9,992 Added 7.3%	146,796 $320,000
Q1 2020 May 14, 2020	BUY	$0.89 - $1.49 $121,755 - $203,837	136,804 New	136,804 $163,000

Others Institutions Holding GERN

# of Institutions

261

Shares Held

449M

Call Options Held

1.91M

Put Options Held

897K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.55B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Geron Corp Transaction History